4
Changes in Ownership
FENNEC PHARMACEUTICALS INC. Filed Acc 0001926254-26-000008
Chief Executive Officer acquired 1,159 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hackman Jeffrey S. Chief Executive Officer | 2026-05-31 | Grant or award | +1,159 | 62,825 | D: show line 1 in the form |
Loading xslF345X06/form4-06012026_040603.xml…